Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inotiv, Inc. Director's Dealing 2020

Dec 30, 2020

34595_dirs_2020-12-30_f02b2b68-b187-4a24-8bf9-6e1e2ac9fbe7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2020-12-29

Reporting Person: Leasure Robert Jr. (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-29 Common Shares A 40000 Acquired 226549 Direct

Footnotes

F1: Represents a restricted grant, which vests in equal installments on the first and second anniversary of the grant date, provided that the grantee is employed by the Company or is serving as a Non-Employee Director of the Company.